FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF21 exerts further anti-inflammatory effects by stimulation of adiponectin, which can enhance lipid and glucose metabolism and therefore mitigate the risk of obesity, diabetes and ASCVD [89].